期刊文献+

纳升电喷雾串联质谱法确证阿托西班的一级结构 被引量:1

Characterization of Primary Structure of Atosiban by Nanoelectrospray Tandem Mass Spectrometry
下载PDF
导出
摘要 利用电喷雾串联质谱对合成八肽阿托西班进行了二硫键还原前后的精确分子量测定和一级结构的确证。首先通过全扫描模式测定了其还原前后的精确分子量,然后选择母离子m/z498.73(双电荷)通过串联质谱(MS/MS)得到碎片离子,采用Y离子的方法测定了阿托西班的序列并对其的修饰位点进行了确证。本方法具有灵敏度高、速度快、样品无需纯化等特点,在多肽类药物一级结构分析方面具有独特的优势。 The molecular weights of unreduced and reduced for the disulfide bond in the atosiban were measured, and the primary structure of atosiban (an artificially synthesized 8AA peptide) was characterized by nanoelectrospray tandem mass spectrometry. Accurate molecular weights were determined firstly by full-scan mass spectrumetry, then fragmentation ions were obtained by selecting parental ions m/z 498. 73 ( double charge) using mass spectrometry(MS/MS) , the sequence and modified site of atosiban were confirmed using Y ion method. The method has the advantages of high sensitivity, fast speed and no need to purify sample and so on. It possess distincrt predominance in the analysis of polypeptide drugs primary structure.
出处 《分析化学》 SCIE CAS CSCD 北大核心 2009年第4期602-604,共3页 Chinese Journal of Analytical Chemistry
关键词 纳升电喷雾串联质谱 阿托西班 二硫键 修饰位点 Nano-electrospray ionization tandem mass spectrometry, atosiban, disulfide bond, modified site
  • 相关文献

参考文献5

二级参考文献30

  • 1丁劲松,彭文兴,张祖华,李焕德,蒋学华.固相萃取结合HPLC-MS测定人血浆中奥曲肽的浓度及相对生物利用度[J].药学学报,2004,39(7):542-545. 被引量:6
  • 2杨世忠,牟伯中,吕应年,陈涛.环脂肽氨基酸顺序的质谱测定[J].化学学报,2004,62(21):2200-2204. 被引量:18
  • 3王红霞,李萍,何家田,周迈,刘炳玉,杨松成,张学敏.人肝癌细胞系HLE细胞表面抗原多肽的纳升电喷雾串联质谱从头测序分析[J].分析化学,2006,34(7):915-918. 被引量:5
  • 4Ingemarsson I, Lamont RF. An update on the controversies of tocolytic therapy for the prevention of pretenn birth. Acta Obstet Gynecol Seand, 2003, 82 : 1-9.
  • 5The Worldwide Atosiban versus Beta-agonists Study Group.Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenerglc agonists in the treatment of preterm labour. Br J Obstet Gynanecol, 2001, 108: 133-142.
  • 6Shim JY, Park YW, Yoon BH, et al. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. Br J Obstet Gynanecol, 2006, 113 : 1228-1234.
  • 7Tsatsaris V, Carbonne B, Cabrol D. Atosiban for preterm labour. Drugs, 2004, 64: 375-382.
  • 8Di Renzo G, Al Saleh E, Mattei A, et al. Use of tocolytics : what is the benefit of gaining 48 hours for the fetus? Br J Obstet Gynanecol, 2006, 113: 72-77.
  • 9Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double, blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol, 2000, 182: 1173-1183.
  • 10Kashanian M, Akbarian AR, Soltanzadeh M. Atosihan and nifedipin for the treatment of preterm labor. Int J Gynaecol Obstet, 2005, 91 : 10-14.

共引文献42

同被引文献27

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部